Novel Neurovascular Protective Agents: Effects of INV-155, INV-157, INV-159, and INV-161 versus Lipoic Acid and Captopril in a Rat Stroke Model

  title={Novel Neurovascular Protective Agents: Effects of INV-155, INV-157, INV-159, and INV-161 versus Lipoic Acid and Captopril in a Rat Stroke Model},
  author={Barry J. Connell and Bobby V. Khan and Desikan Rajagopal and Tarek M Saleh},
  journal={Cardiology Research and Practice},
Background. Lipoic acid (LA), which has significant antioxidant properties, may also function as a potent neuroprotectant. The synthetic compounds INV-155, INV-157, INV-159, and INV-161 are physiochemical combinations of lipoic acid and captopril. We sought to determine if these compounds have neuroprotective potential following middle cerebral artery occlusion (MCAO) in rats. Methods. Male Sprague-Dawley rats were injected intravenously with captopril (1–50 mg/kg) 30 minutes prior to MCAO… 

Figures from this paper

UPEI-400, a conjugate of lipoic acid and scopoletin, mediates neuroprotection in a rat model of ischemia/reperfusion.

Behavioral and Neurochemical Effects of Alpha-Lipoic Acid in the Model of Parkinson's Disease Induced by Unilateral Stereotaxic Injection of 6-Ohda in Rat

This study aimed to investigate behavioral and neurochemical effects of α-lipoic acid (100 mg/kg or 200 mg/kg) alone or associated with L-DOPA using an animal model of Parkinson's disease induced by

Antihypertensive, cardio- and neuro-protective effects of Tenebrio molitor (Coleoptera: Tenebrionidae) defatted larvae in spontaneously hypertensive rats

It is suggested that TM can be considered a new functional food that can lower BP in vivo and thus control cardiovascular-associated risk factors such as hypertension.

The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives.

More extensive research is required in the field of neuropathic pain for the utilization of ACE inhibitors in human, as these may act as a promising factor for future medicine for neurological disorders beyond the cardiovascular actions.

Inhibition of Autophagy by Captopril Attenuates Prion Peptide-Mediated Neuronal Apoptosis via AMPK Activation

Data showed that an anti-hypertensive drug has a protective effect against prion-mediated neuronal cell death via autophagy inhibition and AMPK activation, and suggest that anti- Hypertensive drugs may be effective therapeutic agents against neurodegenerative disorders, including prion diseases.

Design, Synthesis, and Preclinical Bio Evaluation of Chemical Conjugates Derived from Phytophenols and Nitrobenzoate as First Plausible Inhibitors of MPO Useful in CVD Treatment

Phytophenols are important phytonutrients and useful building blocks for medicinal chemistry research. Designed conjugates derived from phytophenols and nitrobenzoate were evaluated for MPO

Neuroprotective Mechanisms of Three Natural Antioxidants on a Rat Model of Parkinson’s Disease: A Comparative Study

The most powerful neuroprotective effect was observed with Myrt, and this work represents the first demonstration of its anti-Parkinsonian impact.



A novel rodent model of reperfusion injury following occlusion of the middle cerebral artery

Estrogen-induced recovery of autonomic function after middle cerebral artery occlusion in male rats.

  • T. SalehA. CribbB. Connell
  • Biology, Psychology
    American journal of physiology. Regulatory, integrative and comparative physiology
  • 2001
It is suggested that both pre- or poststroke estrogen administration prevents or reverses acute stroke-induced autonomic dysfunction and that endogenous estrogen levels in males can contribute to this neuroprotection.

The Impact of Lipoic Acid on Endothelial Function and Proteinuria in Quinapril-Treated Diabetic Patients With Stage I Hypertension

In diabetic patients with hypertension, QUI reduces blood pressure, proteinuria, and improves endothelial function, and this effect is strongly potentiated with a combination of QUI and ALA.

The role of ACE inhibitors in the treatment of hypertensive elderly patients

  • M. Gosch
  • Medicine
    Zeitschrift für Gerontologie und Geriatrie
  • 2000
For a younger population the captopril prevention project showed no differences between ACE inhibitors and conventional antihypertensive treatment (diuretics, beta-blocker) concerning the primary endpoints (myocardial infarction, stroke and other cardiovascular death).

Blood pressure and the global burden of disease 2000. Part 1: Estimates of blood pressure levels

These global estimates of blood pressure by age, sex and subregion show considerable variation in estimated levels, and the lack of data in developing countries is substantial, and this is an important limitation given the role ofBlood pressure in increasing cardiovascular disease levels.

Hypertension and cerebrovascular disease.

Hypertension in acute phase of ischaemic stroke should not be treated but in advanced centres with specialised stroke units, the favoured drugs are short acting vasodilators e.g., sodium nitroprusside and labetalol.

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

Cardiovascular disease and all-cause mortality are increased in men with the metabolic syndrome, even in the absence of baseline CVD and diabetes, according to the Kuopio Ischaemic Heart Disease Risk Factor Study.

Cardiovascular disease and African Americans: why determination of race is inadequate for research and practice.

  • K. Ferdinand
  • Medicine
    Journal of the National Medical Association
  • 2007